Improving Adjuvant Endocrine Treatment Tailoring in Premenopausal Women With Hormone Receptor-Positive Breast Cancer

被引：31

作者：

Lambertini, Matteo ^{[1
,2
]}

Blondeaux, Eva ^{[1
]}

Perrone, Francesco ^{[3
]}

Del Mastro, Lucia ^{[1
,2
]}

机构：

[1] IRCCS Osped Policlin San Martino, Genoa, Italy

[2] Univ Genoa, Genoa, Italy

[3] IRCCS Fdn G Pascale, Ist Nazl Tumori, Naples, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 12期

关键词：

OVARIAN-FUNCTION SUPPRESSION; INTERNATIONAL CONSENSUS GUIDELINES; PATIENT-REPORTED OUTCOMES; PLUS ZOLEDRONIC ACID; QUALITY-OF-LIFE; CLINICAL-PRACTICE; YOUNG-WOMEN; ITALIAN ASSOCIATION; FERTILITY CONCERNS; AMERICAN SOCIETY;

D O I：

10.1200/JCO.19.02242

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice.

引用

页码：1258 / +

页数：11

共 70 条

[1]

[Anonymous], J CLIN ONCOL

[2] Genomic aberrations in young and elderly breast cancer patients [J].

Azim, Hatem A., Jr. ;

Nguyen, Bastien ;

Brohee, Sylvain ;

Zoppoli, Gabriele ;

Sotiriou, Christos .

BMC MEDICINE, 2015, 13

[3] Biology of breast cancer in young women [J].

Azim, Hatem A., Jr. ;

Partridge, Ann H. .

BREAST CANCER RESEARCH, 2014, 16 (04)

[4] HER2 status predicts for upfront AI benefit: A TRANS-AIOG meta-analysis of 12,129 patients from ATAC, BIG 1-98 and TEAM with centrally determined HER2 [J].

Bartlett, John M. S. ;

Ahmed, Ikhlaaq ;

Regan, Meredith M. ;

Sestak, Ivana ;

Mallon, Elizabeth A. ;

Dell'Orto, Patrizia ;

Thurlimann, Beat ;

Seynaeve, Caroline ;

Putter, Hein ;

Van de Velde, Cornelis J. H. ;

Brookes, Cassandra L. ;

Forbes, John F. ;

Viale, Giuseppe ;

Cuzick, Jack ;

Dowsett, Mitchell ;

Rea, Daniel W. .

EUROPEAN JOURNAL OF CANCER, 2017, 79 :129-138

[5] Twelve-Month Estrogen Levels in Premenopausal Women With Hormone Receptor-Positive Breast Cancer Receiving Adjuvant Triptorelin Plus Exemestane or Tamoxifen in the Suppression of Ovarian Function Trial (SOFT): The SOFT-EST Substudy [J].

Bellet, Meritxell ;

Gray, Kathryn P. ;

Francis, Prudence A. ;

Lang, Istvan ;

Ciruelos, Eva ;

Lluch, Ana ;

Angel Climent, Miguel ;

Catalan, Gustavo ;

Avella, Antoni ;

Bohn, Uriel ;

Gonzalez-Martin, Antonio ;

Ferrer, Roser ;

Catalan, Roberto ;

Azaro, Analia ;

Rajasekaran, Agnita ;

Morales, Josefa ;

Vazquez, Josep ;

Fleming, Gini F. ;

Price, Karen N. ;

Regan, Meredith M. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (14) :1584-U89

[6] Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials [J].

Bernhard, Juerg ;

Luo, Weixiu ;

Ribi, Karin ;

Colleoni, Marco ;

Burstein, Harold J. ;

Tondini, Carlo ;

Pinotti, Graziella ;

Spazzapan, Simon ;

Ruhstaller, Thomas ;

Puglisi, Fabio ;

Pavesi, Lorenzo ;

Parmar, Vani ;

Regan, Meredith M. ;

Pagani, Olivia ;

Fleming, Gini F. ;

Francis, Prudence A. ;

Price, Karen N. ;

Coates, Alan S. ;

Gelber, Richard D. ;

Goldhirsch, Aron ;

Walley, Barbara A. .

LANCET ONCOLOGY, 2015, 16 (07) :848-858

[7] Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019 [J].

Burstein, H. J. ;

Curigliano, G. ;

Loibl, S. ;

Dubsky, P. ;

Gnant, M. ;

Poortmans, P. ;

Colleoni, M. ;

Denkert, C. ;

Piccart-Gebhart, M. ;

Regan, M. ;

Senn, H. -J. ;

Winer, E. P. ;

Thurlimann, B. .

ANNALS OF ONCOLOGY, 2019, 30 (10) :1541-1557

[8] Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update [J].

Burstein, Harold J. ;

Lacchetti, Christina ;

Anderson, Holly ;

Buchholz, Thomas A. ;

Davidson, Nancy E. ;

Gelmon, Karen A. ;

Giordano, Sharon H. ;

Hudis, Clifford A. ;

Solky, Alexander J. ;

Stearns, Vered ;

Winer, Eric P. ;

Griggs, Jennifer J. .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (05) :423-+

[9] Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression [J].

Burstein, Harold J. ;

Lacchetti, Christina ;

Anderson, Holly ;

Buchholz, Thomas A. ;

Davidson, Nancy E. ;

Gelmon, Karen E. ;

Giordano, Sharon H. ;

Hudis, Clifford A. ;

Solky, Alexander J. ;

Stearns, Vered ;

Winer, Eric P. ;

Griggs, Jennifer J. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (14) :1689-U250

[10] Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update [J].

Burstein, Harold J. ;

Temin, Sarah ;

Anderson, Holly ;

Buchholz, Thomas A. ;

Davidson, Nancy E. ;

Gelmon, Karen E. ;

Giordano, Sharon H. ;

Hudis, Clifford A. ;

Rowden, Diana ;

Solky, Alexander J. ;

Stearns, Vered ;

Winer, Eric P. ;

Griggs, Jennifer J. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (21) :2255-+

← 1 2 3 4 5 6 7 →